Harvard Bioscience
HBIO
HBIO
94 hedge funds and large institutions have $84.2M invested in Harvard Bioscience in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $90.7M → $84.2M (-$6.51M)
33% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 18
92% less call options, than puts
Call options by funds: $2K | Put options by funds: $26K
Holders
94
Holding in Top 10
1
Calls
$2K
Puts
$26K
Top Buyers
| 1 | +$508K | |
| 2 | +$424K | |
| 3 | +$263K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$255K |
| 5 |
Morgan Stanley
New York
|
+$254K |
Top Sellers
| 1 | -$591K | |
| 2 | -$515K | |
| 3 | -$398K | |
| 4 |
Millennium Management
New York
|
-$367K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$328K |